• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer
  • Advertise
  • Subscribe

MassDevice

The Medical Device Business Journal — Medical Device News & Articles | MassDevice

  • Latest News
  • Technologies
    • Artificial Intelligence (AI)
    • Cardiovascular
    • Orthopedics
    • Neurological
    • Diabetes
    • Surgical Robotics
  • Business & Finance
    • Wall Street Beat
    • Earnings Reports
    • Funding Roundup
    • Mergers & Acquisitions
    • Initial Public Offering (IPO)
    • Legal News
    • Personnel Moves
    • Medtech 100 Stock Index
  • Regulatory & Compliance
    • Food & Drug Administration (FDA)
    • Recalls
    • 510(k)
    • Pre-Market Approval (PMA)
    • MDSAP
    • Clinical Trials
  • Special Content
    • Special Reports
    • In-Depth Coverage
    • DeviceTalks
  • Podcasts
    • MassDevice Fast Five
    • DeviceTalks Weekly
    • OEM Talks
      • AbbottTalks
      • Boston ScientificTalks
      • DeviceTalks AI
      • IntuitiveTalks
      • MedtechWOMEN Talks
      • MedtronicTalks
      • Neuro Innovation Talks
      • Ortho Innovation Talks
      • Structural Heart Talks
      • StrykerTalks
  • Resources
    • About MassDevice
    • DeviceTalks
    • Newsletter Signup
    • Leadership in Medtech
    • Manufacturers & Suppliers Search
    • MedTech100 Index
    • Videos
    • Webinars
    • Whitepapers
    • Voices
Home » Medtronic wins EU approval for MRI-safe Activa DBS devices

Medtronic wins EU approval for MRI-safe Activa DBS devices

April 22, 2015 By Brad Perriello

Medtronic wins EU approval for MRI-safe Activa DBS devices

Medtronic (NYSE:MDT) said today that it won European approval for full-body MRI scans of patients implanted with its Activa deep-brain stimulation device.

The Fridley, Minn.-based medical technology giant said the expanded approval applies to patients receiving the Activa implant for the 1st time, plus some 13,000 European patients already implanted with Medtronic DBS devices.

"Medtronic is proud to be the only company to offer DBS systems to patients across Europe allowing them access to full-body MRI technology," vice president Lothar Krinke said in prepared remarks. "Additionally, now patients with MR conditional systems will be able to continue to receive the benefits of the therapy during the scanning procedure. Continuous advancements such as these set Medtronic apart and reinforce our commitment to the field of brain modulation."

Medtronic’s DBS therapy is approved in various jurisdictions for indications including essential tremor, Parkinson’s disease and chronic intractable primary dystonia, refractory epilepsy, and severe, treatment-resistant obsessive-compulsive disorder, the company said.

The devices were previously approved under limited conditions only for MRI scans of the head, according to a press release.

"MRI is commonly the method of choice to image the body to diagnose disease or monitor existing conditions, but MRI use has often been limited in patients receiving DBS therapy," Dr. John Thornton of London’s National Hospital for Neurology & Neurosurgery said the release. "Patients receiving DBS therapy can now receive more advantages of MRI technology."

Filed Under: News Well, Regulatory/Compliance Tagged With: CE Mark, Deep-brain stimulation

More recent news

  • Breaking: Sequel to launch twiist automated insulin delivery system next month
  • Dexcom shares U.S. report on CGM benefits for type 2 diabetes
  • Data backs Medtronic MiniMed 780G for type 2, children as company seeks expanded indications
  • Endogenex data supports type 2 diabetes procedure
  • Ambu wins FDA clearance for first single-use cysto-nephroscope

Primary Sidebar

“md
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest med device regulatory, business and technology news.

DeviceTalks Weekly

See More >

MEDTECH 100 Stock INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
MDO ad

Footer

MASSDEVICE MEDICAL NETWORK

DeviceTalks
Drug Delivery Business News
Medical Design & Outsourcing
Medical Tubing + Extrusion
Drug Discovery & Development
Pharmaceutical Processing World
MedTech 100 Index
R&D World
Medical Design Sourcing

DeviceTalks Webinars, Podcasts, & Discussions

Attend our Monthly Webinars
Listen to our Weekly Podcasts
Join our DeviceTalks Tuesdays Discussion

MASSDEVICE

Subscribe to MassDevice E-Newsletter
Advertise with us
About
Contact us

Copyright © 2025 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Privacy Policy